Preventing stroke in patients with transient ischemic attacks

American Family Physician

Volumn 60, Issue 8, 1999, Pages 2329-2341

  Ryan, Melody ^a   Combs, Greta ^a   Penix, Laroy P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PLACEBO; TICLOPIDINE; WARFARIN;

CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CAUSE OF DEATH; CLINICAL TRIAL; COMORBIDITY; DISABILITY; DRUG EFFICACY; HUMAN; REVIEW; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADULT; CEREBROVASCULAR ACCIDENT; DIAGNOSIS, DIFFERENTIAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PATIENT EDUCATION; TEACHING MATERIALS;

EID: 0033571815     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Caplan LR. Introduction and perspective. In: Caplan LR, ed. Stroke: a clinical approach. Boston: Butterworth-Heinemann, 1993:3-22.
2. Heart and stroke statistical update. Dallas: American Heart Association, 1998.
3. Pessin MS, Duncan GW, Mohr JP, Poskanzer DC. Clinical and angiographic features of carotid transient ischemic attacks. N Engl J Med 1977;296: 358-62.
4. Guidelines for the management of transient ischemic attacks. Stroke 1994;25:1320-35.
5. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes. Am J Med 1983;74:540-4.
6. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999;281:1112-20.
7. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46 [Published erratum in Arch Intern Med 1998;158:573].
8. Matchar DB, McCrory DC, Barnett HJ, Feussner JR. Medical treatment for stroke prevention Ann Intern Med 1994;121:41-53 [Published errata in Ann Intern Med 1994;121:470 and 1995;122:885].
9. Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. BMJ 1998;316:1303-9 [Published erratum in BMJ 1998; 316:1733].
10. Cairns JA, Theroux P, Lewis HD Jr, Ezekowitz M, Meade TW, Sutton GC. Antithrombotic agents in coronary artery disease. Chest 1998;114[5 suppl]: 611S-33S.
11. Albers GW, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 1998;114(5 suppl):683S-98S.
12. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 1996;28:1328-428.
13. Bucher HC, Griffith LE, Gyuyatt GH. Effect of HMG-coA reductase inhibitors on stroke. Ann Intern Med 1998;128:89-95.
14. Blauw GJ, Lagaay AM, Smelt AH, Westendorp RG. Stroke, statins, and cholesterol. Stroke 1997;28: 946-50.
15. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 1997;278:313-21.
16. Delanty N, Vaughan CJ. Vascular effects of statins in stroke. Stroke 1997;28:2315-20.
17. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit. Circulation 1995;91:2274-82.
18. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 1998;114(5 suppl):579S-89S.
19. American Diabetes Association: clinical practice recommendations 1998. Diabetes Care 1998;21 (suppl 1):S1-89.
20. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
21. Summary of the second report of the National Cholesterol Education Program (NCEP) Expect Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
22. Woolf SH. Practice guidelines: a new reality in medicine. I. Recent developments. Arch Intern Med 1990;150:1811-8.
23. The Canadian guide to clinical preventive health care. Ottawa, Ontario: Canada Communication Group Publishing, 1994.
24. Findlay JM, Tucker WS, Ferguson GG, Holness RO, Wallace MC, Wong JH. Guidelines for the use of carotid endarterectomy. CMAJ 1997;157:653-9.
25. Management of patients with stroke: part II. Management of carotid stenosis and carotid endarterectomy. Scottish Intercollegiate Guidelines Network. Retrieved September 6, 1999, from the World Wide Web: http://pc47.cee.hw.ac.uk/sign/pdf/sign14.pdf.
26. Guidelines for medical treatment for stroke prevention. Ann Intern Med 1994;121:54-5.
27. Perry JR, Szalai JP, Norris JW. Consensus against both endarterectomy and routine screening for asymptomatic carotid artery stenosis. Arch Neural 1997;54:25-8.
28. Guide to clinical preventive services. report of the U.S. Preventive Services Task Force. Baltimore: Williams & Wilkins, 1996:xcii,953.
29. Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, Dempsey RJ, et al. Guidelines for carotid endarterectomy. Circulation 1998;97:501-9.
30. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, et al. Physical activity and public health. JAMA 1995;273:402-7.
31. Physical activity and cardiovascular health. JAMA 1996;276:241-6.
32. MacMahon S, Rodgers A. Blood pressure, antihypertensive treatment and stroke risk. J Hypertens Suppl 1994,12:S5-14.
33. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med 1995;333:1392-400.
34. Stroke Prevention in Atrial Fibrillation Study Final results. Circulation 1991;84:527-39.
35. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-91.
36. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995;333:5-10.
37. Life-saving treatments to prevent stroke underused. AHCPR press release Sept. 7, 1995. Retrieved September 6, 1999, from the World Wide Web: http://www.ahcpr.gov/news/press/stroke.htm.
38. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-8.
39. Malinow MR. Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases. J Nutr 1996;126(4 suppl):1238S-43S.
40. Gillman MW, Cupples LA, Millen BE, Ellison RC, Wolf PA. Inverse association of dietary fat with development of ischemic stroke in men. JAMA 1997;278:2145-50.
41. Crouse JR 3d, Byington RP, Hoen HM, Furberg CD. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med 1997;157:1305-10.
42. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (45). Lancet 1994; 344:1383-9.
43. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham study. Stroke 1994; 25:40-3.
44. Pederson AT, Lidegaard O, Kreiner S, Ottesen B. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997;350:1277-83.
45. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch Intern Med 1993;153:73-9.
46. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K. Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 1987;257:949-52.
47. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53.
48. Streifler JY, Benavente OR, Harbison JW, Eliasziw M, Hachinski VC, Barnett HJ. Prognostic implications of retinal versus hemispheric TIA in patients with high-grade carotid stenosis: observations from NASCET [Abstract], Stroke 1992:26:159.
49. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998;339:1415-25.
50. Overmyer RH. Treating atherosclerotic disease: current strategies. Formulary 1998;33(suppl 1):S3-12.
51. Raps EC, Galetta SL. Stroke prevention therapies and management of patient subgroups. Neurology 1995;45(2 suppl 1):S19-24.
52. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom Transient Ischaemic Attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044-54.
53. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991;325:1261-6.
54. European Stroke Prevention Study (ESPS). Principal end-points. Lancet 1987;2(8572):1351-4.
55. Bousser MG, Eschwege E, Haguenau M, Lefaucconier JM, Thibult N, Touboul D, et al. "AICLA": controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke 1983;14:5-14.
56. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemic events. Lancet 1991;338:1345-49.
57. Theroux P. Antiplatelet therapy in coronary disease: what agent to use, when, and how? J Thromb Thrombol 1998;5(suppl 1):S143-50.
58. Schror K. Antiplatelet drugs. A comparative review. Drugs 1995;50:7-28.
59. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;1(8649):1215-20.
60. Mass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, et al. A randomized trial comparing tidopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-7.
61. Tidopidine [package insert]. Nutley, N.J.: Roche Laboratories, 1998.
62. Coukel AJ, Markham A. Clopidogrel. Drugs 1997; 54:745-50.
63. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
64. Plavix [pacckage insert]. New York: Sanofi Pharmaceuticals, 1997.
65. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997;42:857-65.
66. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study Neurology 1995;45:1488-93.